Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Izumi, Yuishin
NCT04744532: iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study	Recruiting	1/2	49	Japan	Bosutinib (Phase 1 part), PF-05208763, Bosutinib (Phase 2 part)	Kyoto University, Tokushima University, Kitasato University, Tottori University, Nara Medical University, Toho University, Hiroshima University, Pfizer	Amyotrophic Lateral Sclerosis	03/24	03/24
Noma, Takayuki
T1CR, NCT06314971: Predicting Local and Distant Recurrence in T1 Colorectal Cancer	Recruiting	N/A	200	Europe, Japan, US	Tw1CE, T1 Colorectal cancer rEcurrence (Tw1CE)	City of Hope Medical Center	Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage I, Colorectal Neoplasms Malignant, Colorectal Cancer Recurrent	03/25	03/25
NCT06654622: Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer.	Recruiting	N/A	200	US		City of Hope Medical Center	Colo-rectal Cancer, Colorectal Cancer Recurrent	12/24	12/24
LyMIC, NCT06381648: Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma	Recruiting	N/A	200	Japan, US	LyMIC (Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma)	City of Hope Medical Center	Cholangiocarcinoma, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma Resectable, Cholangiocarcinoma; Liver	06/26	06/26
Yoshizumi, Tomoharu
ELUCIDATE, NCT06342414: An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer	Recruiting	N/A	400	Japan, US	ELUCIDATE, ELUCIDATE (Evaluation of Liver Cholangiocarcinoma Intrahepatic)	City of Hope Medical Center	Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma, Primary Liver Cancer, Primary Liver Carcinoma, Hepatic Cancer, Hepatic Carcinoma	03/25	03/25